Login
$TXG
$54.51 After hours

Who owns 10x?

Institutions own, across all of 10x's classes
—
of the economics
—
of the votes

The 13F holdings add up to more than the shares outstanding, so they are not shown until the filings are checked.

By class
Class Shares outstanding Held by institutions Votes a share Economics a share
TXG 121.5M — 1 vote 1
Class B 10.1M — 10 votes 1

SEC filing txg-20251231.htm: Year Ended December 31, 2025 2024 2023 Class B common stock converted to Class A common stock 3,977,961 — 4,610,422 The Company’s Class A common stock and Class B common stock have a par value of $0.00001 per share. Each share of Class B common stock has the right to ten votes and each share of Class A common stock has the right to one vote per share. All other rights and privileges of Class A ...

How is ownership changing?

Institutions, last 8 quarters

A trend across this company's share classes isn't available yet: each quarter's 13F filings add up shares of classes that differ in economics and votes.

Biggest buyers in Q2 2026
  • Price T Rowe Associates Inc /MD/ +4.4M
  • Citadel Advisors LLC +2.0M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Millennium Management LLC −2.0M
  • ARK Investment Management LLC −1.7M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$15.4M
21 notices from 8 people
Arranged in advance
55%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$3.5M$7.1MDecJanFeb 2026: $147.1K under a 10b5-1 planFeb 2026: $530.0K without a planFebMar 2026: $910.7K under a 10b5-1 planMarAprMay 2026: $964.2K under a 10b5-1 planMay 2026: $966.4K without a planMayJun 2026: $184.4K under a 10b5-1 planJunJulAug 2026: $2.8M under a 10b5-1 planAug 2026: $4.3M without a planAugSep 2026: $3.4M under a 10b5-1 planSep 2026: $1.2M without a planSepOctNov
Largest proposed sellers
  • Serge Saxonov Director, ceo 10b5-1 $4.08M
  • Adam Taich Officer 10b5-1 $3M

Sign up to see all 5.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2019–FY2025
+219.1%
+21.34% a year
Each share's claim on the business
−68.7%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $712M
over 7 fiscal years
Diluted shares, split-adjusted
37.9M82.0M126.0M2019: 39.1M shares'192020: 101.2M shares'202021: 110.3M shares'212022: 113.9M shares'222023: 117.2M shares'232024: 120.5M shares'242025: 124.7M shares'25
Buybacks Stock-based comp
$0$83.5M$167.0M2019 buybacks: $02019 stock comp: $13.3M'192020 buybacks: $02020 stock comp: $48.6M'202021 buybacks: $02021 stock comp: $96.0M'212022 buybacks: $02022 stock comp: $136.8M'222023 buybacks: $02023 stock comp: $167.0M'232024 buybacks: $02024 stock comp: $140.7M'242025 buybacks: $02025 stock comp: $109.1M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years69% 3–5 years8% 1–3 years8% Under 1 year15%
Quarterly turnover
14.3%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting 10x on Form 13F
F
FMR LLC
Shares
17.6M
% of company
—
Change vs last qtr
−111.7K (−0.6%)
Held since
≤2021
AI
ARK Investment Management LLC
Shares
10.0M
% of company
—
Change vs last qtr
−1.7M (−14.6%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding 10x Genomics, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting 10x on Form N-PORT
AI
ARK ETF Trust
Position value
$184M
% of company
—
% of the fund
3.30%
As of
July 31, 2026
AG
Position value
$146M
% of company
—
% of the fund
9.39%
As of
July 31, 2026

23 more funds behind a free account

See every fund holding 10x Genomics, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
RB
Roberts Bryan E
Insider
Shares
6.4M
% of company
—
Change vs last qtr
—
Held since
—
SS
Saxonov Serge
Insider
Shares
1.2M
% of company
—
Change vs last qtr
—
Held since
—

9 more holders behind a free account

See every insider and 5%+ holder of 10x Genomics, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support